PCN13 Comparison of Nab-paclitaxel PLUS Gemcitabine Versus S-1 PLUS Gemcitabine in First LINE Treatment of Metastatic Pancreatic Cancer in China: A Cost-Effectiveness Analysis
Abstract
Authors
S. Qu L. Wang X. Zhang Y. Liu C. Ye J. Cui